Comparison of value of biomarkers in diagnosing lung cancer: An overview of systematic reviews protocol.

ABSTRACT:

Background

In both sexes combined, lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death. Furthermore, the incidence rate is increasing in many countries. Many lung cancer patients have a poor prognosis because they are usually diagnosed at an advanced stage. Therefore, there is an urgent need to develop effective methods for early diagnosis of lung cancer. Some systematic reviews have evaluated the value of biomarkers for diagnosing lung cancer. However, it remains unclear which biomarker has superior performance for early and accurate detection of lung cancer. This overview aims to assess the methodological and reporting quality of available systematic reviews and to find an optimal biomarker for diagnosing lung cancer.

Methods

We searched

SUBMITTER: Wu F 

PROVIDER: S-EPMC6531075 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature